| |
|---|
|
|||||||||||||||||||||||||
Lilly’s diabetes drug outshines world’s most popular insulin
World News | May 13, 2014
Late-stage clinical data has shown Lilly’s experimental diabetes drug Peglispro to be better at reducing blood sugar in patients with type II diabetes than Sanofi’s Lantus – the world’s most prescribed insulin.
The US drugmaker says it expects to file for approval of its basal insulin (BIL) by the first quarter of next year, after three Phase III studies showed it induced “a statistically superior reduction in HbA1c” compared with Lantus.
………….
Filed under: DIABETES Tagged: DIABETES, peglispro
